Eton Pharmaceuticals: Q3 Earnings Insights
Eton Pharmaceuticals (NASDAQ:ETON) reported its Q3 earnings results on Thursday, November 9, 2023 at 04:01 PM. Here’s what…
Earnings Scheduled For November 9, 2023
Companies Reporting Before The Bell
• Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on revenue of $265.00 million.
Why Maxeon Solar Technologies Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Friday’s Mid-Day Session
Gainers
Amyris, Inc. (NASDAQ: AMRS) shares jumped 179.1% to $0.1839. Amyris shares dipped over 80% on Thursday after the company announced it filed for Chapter 11 bankruptcy.
12 Health Care Stocks Moving In Friday’s Intraday Session
Gainers Tango Therapeutics (NASDAQ:TNGX) shares increased by 20.2% to $7.87 during Friday’s regular session. As of 13:31 EST,…
Consolidated Water, Spectrum Brands, Arco Platform, Semler Scientific And Other Big Stocks Moving Higher On Friday
U.S. stocks traded mixed, with the Dow Jones gaining around 80 points on Friday. Here are some big stocks recording gains in today’s session.
12 Health Care Stocks Moving In Friday’s Pre-Market Session
Gainers Eton Pharmaceuticals (NASDAQ:ETON) shares increased by 32.3% to $3.44 during Friday’s pre-market session. The company’s market cap…
Why Semler Scientific Shares Are Trading Higher By 40%; Here Are 20 Stocks Moving Premarket
Gainers
Amyris, Inc. (NASDAQ: AMRS) shares surged 45.4% to $0.0958 in pre-market trading. Amyris shares dipped over 80% on Thursday after the company announced it filed for Chapter 11 bankruptcy.
12 Health Care Stocks Moving In Thursday’s After-Market Session
Gainers Semler Scientific (NASDAQ:SMLR) shares moved upwards by 25.5% to $29.45 during Thursday’s after-market session. This security traded…
Earnings Scheduled For August 10, 2023
Companies Reporting Before The Bell
• IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million.
Wells Fargo To Rally Around 20%? Here Are 10 Other Analyst Forecasts For Monday
Jefferies boosted the price target for ACM Research, Inc. (NASDAQ: ACMR) from $9 to $23.4. Jefferies analyst Nick Cheng upgraded the stock from Underperform to Buy. ACM Research shares fell 2.2% to close at $13.08 on Friday.